Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000075.xml
Download PDF
Semin Respir Crit Care Med 2005; 26(5): 482-489
DOI: 10.1055/s-2005-922031
DOI: 10.1055/s-2005-922031
Graft versus Host-Associated Pulmonary Disease and other Idiopathic Pulmonary Complications after Hematopoietic Stem Cell Transplant
Further Information
Publication History
Publication Date:
02 November 2005 (online)
ABSTRACT
Noninfectious conditions are now the major pulmonary causes of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). The idiopathic pneumonia syndrome (IPS) remains one of the more common and serious pulmonary complications within months after transplantation. Epidemiological data suggest that, although graft versus host disease (GVHD) reactions may play an etiological role, the major contributing factor is conditioning-related toxicity. Among lung conditions that are more closely associated with GVHD are both obliterative bronchiolitis (usually occurring months to years after HSCT) and bronchiolitis obliterans organizing pneumonia (BOOP). The former is an inexorably progressive condition, whereas BOOP behaves similarly to idiopathic BOOP seen in other populations. Also addressed in this article are engraftment syndrome, diffuse alveolar hemorrhage, and pulmonary veno-occlusive disease. Knowledge of these complications is now a part of the contemporary practice of pulmonary medicine, no longer isolated to the transplant pulmonologist.
KEYWORDS
Hematopoietic stem cell transplantation - pneumonia - graft versus host disease - bronchiolitis obliterans - airflow obstruction
REFERENCES
- 1 Krowka M J, Rosenow III E C, Hoagland H C. Pulmonary complications of bone marrow transplantation. Chest. 1985; 87 237-246
- 2 Soubani A O, Miller K B, Hassoun P M. Pulmonary complications of bone marrow transplantation. Chest. 1996; 109 1066-1077
- 3 Afessa B, Litzow M R, Tefferi A. Bronchiolitis obliterans and other late onset noninfectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001; 28 425-434
- 4 Yousem S A. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol. 1995; 26 668-675
- 5 Cooke K R, Yanik G. Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?. Bone Marrow Transplant. 2004; 34 753-765
- 6 Meyers J D, Flournoy N, Thomas E D. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis. 1982; 4 1119-1132
- 7 Clark J G, Hansen J A, Hertz M I, Parkman R, Jensen L, Peavy H H. NHLBI workshop summary: idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis. 1993; 147(Pt 1) 1601-1606
- 8 Kantrow S P, Hackman R C, Boeckh M, Myerson D, Crawford S W. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation. 1997; 63 1079-1086
- 9 Fukuda T, Hackman R C, Guthrie K A et al.. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood. 2003; 102 2777-2785
- 10 Weiner R S, Bortin M M, Gale R P et al.. Interstitial pneumonitis after bone marrow transplantation: assessment of risk factors. Ann Intern Med. 1986; 104 168-175
- 11 Wingard J R, Mellits E D, Sostrin M B et al.. Interstitial pneumonitis after allogeneic bone marrow transplantation: nine-year experience at a single institution. Medicine (Baltimore). 1988; 67 175-186
- 12 Cordonnier C, Bernaudin J F, Bierling P, Huet Y, Vernant J P. Pulmonary complications occurring after allogeneic bone marrow transplantation: a study of 130 consecutive transplanted patients. Cancer. 1986; 58 1047-1054
- 13 Cane P A, van den Hoogen B G, Chakrabarti S, Fegan C D, Osterhaus A D. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant. 2003; 31 309-310
- 14 Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant. 2001; 5 320-330
- 15 Panoskaltsis-Mortari A, Taylor P A, Yaeger T M et al.. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J Clin Invest. 1997; 100 1015-1027
- 16 Cooke K R, Krenger W, Hill G et al.. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood. 1998; 92 2571-2580
- 17 Cooke K R, Hill G R, Gerbitz A et al.. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation. 2000; 70 272-279
- 18 Cooke K R, Kobzik L, Martin T R et al.. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation, I: The roles of minor H antigens and endotoxin. Blood. 1996; 88 3230-3239
- 19 Panoskaltsis-Mortari A, Strieter R M, Hermanson J R et al.. Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation. Blood. 2000; 96 834-839
- 20 Bhalla K S, Folz R J. Idiopathic pneumonia syndrome after syngeneic bone marrow transplant in mice. Am J Respir Crit Care Med. 2002; 166(Pt 1) 1579-1589
- 21 Bhalla K S, Wilczynski S W, Abushamaa A M et al.. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support. Am J Respir Crit Care Med. 2000; 161 17-25
- 22 Duncker C, Dohr D, Harsdorf S et al.. Noninfectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant. 2000; 25 1263-1268
- 23 Yanik G, Hellerstedt B, Custer J et al.. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2002; 8 395-400
- 24 Robbins R A, Linder J, Stahl M G et al.. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med. 1989; 87 511-518
- 25 Afessa B, Tefferi A, Litzow M R, Krowka M J, Wylam M E, Peters S G. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002; 166 641-645
- 26 Agusti C, Ramirez J, Picado C et al.. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation: a postmortem study. Am J Respir Crit Care Med. 1995; 151 1006-1010
- 27 Afessa B, Tefferi A, Litzow M R, Peters S G. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002; 166 1364-1368
- 28 Afessa B, Tefferi A, Hoagland H C, Letendre L, Peters S G. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992; 67 117-122
- 29 Metcalf J P, Rennard S I, Reed E C et al.. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group. Am J Med. 1994; 96 327-334
- 30 Chao N J, Duncan S R, Long G D, Horning S J, Blume K G. Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Ann Intern Med. 1991; 114 145-146
- 31 Spitzer T R. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001; 27 893-898
- 32 Maiolino A, Biasoli I, Lima J, Portugal A C, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant. 2003; 31 393-397
- 33 Marin D, Berrade J, Ferra C et al.. Engraftment syndrome and survival after respiratory failure post-bone marrow transplantation. Intensive Care Med. 1998; 24 732-735
- 34 Lee C K, Gingrich R D, Hohl R J, Ajram K A. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant. 1995; 16 175-182
- 35 Capizzi S A, Kumar S, Huneke N E et al.. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001; 27 1299-1303
- 36 Chien J W, Martin P J, Gooley T A et al.. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2003; 168 208-214
- 37 Clark J G, Crawford S W, Madtes D K, Sullivan K M. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course. Ann Intern Med. 1989; 111 368-376
- 38 Paz H L, Crilley P, Patchefsky A, Schiffman R L, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest. 1992; 101 775-778
- 39 Chan C K, Hyland R H, Hutcheon M A et al.. Small-airways disease in recipients of allogeneic bone marrow transplants: an analysis of 11 cases and a review of the literature. Medicine (Baltimore). 1987; 66 327-340
- 40 Ralph D D, Springmeyer S C, Sullivan K M, Hackman R C, Storb R, Thomas E D. Rapidly progressive air-flow obstruction in marrow transplant recipients: possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis. 1984; 129 641-644
- 41 Curtis D J, Smale A, Thien F, Schwarer A P, Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995; 16 169-173
- 42 Schultz K R, Green G J, Wensley D et al.. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood. 1994; 84 3212-3220
- 43 Philit F, Wiesendanger T, Archimbaud E, Mornex J F, Brune J, Cordier J F. Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J. 1995; 8 551-558
- 44 Palmas A, Tefferi A, Myers J L et al.. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol. 1998; 100 680-687
- 45 St John R C, Gadek J E, Tutschka P J, Kapoor N, Dorinsky P M. Analysis of airflow obstruction by bronchoalveolar lavage following bone marrow transplantation: implications for pathogenesis and treatment. Chest. 1990; 98 600-607
- 46 Clark J G, Schwartz D A, Flournoy N, Sullivan K M, Crawford S W, Thomas E D. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med. 1987; 107 648-656
- 47 Holland H K, Wingard J R, Beschorner W E, Saral R, Santos G W. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood. 1988; 72 621-627
- 48 Sanchez J, Torres A, Serrano J et al.. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997; 20 403-408
- 49 Salzman D, Adkins D R, Craig F, Freytes C, LeMaistre C F. Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review. Bone Marrow Transplant. 1996; 18 755-760
- 50 Troussard X, Bernaudin J F, Cordonnier C et al.. Pulmonary veno-occlusive disease after bone marrow transplantation. Thorax. 1984; 39 956-957
- 51 Hackman R C, Madtes D K, Petersen F B, Clark J G. Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation. 1989; 47 989-992
- 52 Williams L M, Fussell S, Veith R W, Nelson S, Mason C M. Pulmonary veno-occlusive disease in an adult following bone marrow transplantation: case report and review of the literature. Chest. 1996; 109 1388-1391
- 53 Mandel J, Mark E J, Hales C A. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000; 162 1964-1973
- 54 Doll D C, Yarbro J W. Vascular toxicity associated with antineoplastic agents. Semin Oncol. 1992; 19 580-596
- 55 Ishii T, Manabe A, Ebihara Y et al.. Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin. Bone Marrow Transplant. 2000; 26 907-910
- 56 Baron F A, Hermanne J P, Dowlati A et al.. Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1998; 21 951-954
- 57 Kanda Y, Takahashi T, Imai Y et al.. Bronchiolitis obliterans organizing pneumonia after syngeneic bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant. 1997; 19 1251-1253
- 58 Freudenberger T D, Madtes D K, Curtis J R et al.. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood. 2003; 102 3822-3828
Stephen W CrawfordM.D.
Pulmonary and Critical Care Medicine, Naval Medical Center San Diego, 34730 Bob Wilson
Dr., Ste. 301, San Diego, CA 92134-3301
Email: SWCrawford@nmcsd.med.nav.mil